|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 12-20-2004
MUNICH/AMSTERDAM (Reuters) - Radio waves from mobile phones harm body cells and damage DNA in laboratory conditions, according to a new study majority-funded by the European Union, researchers said on Monday.
FRANKFURT (Reuters) - Germany's drug regulator on Monday told patients with cardiovascular risks to stop using Pfizer's arthritis drug Celebrex after new data emerged linking it to an elevated risk of heart attacks.
KAMPALA (Reuters) - A key anti-HIV/AIDS drug distributed in Africa causes drug resistance in pregnant women, but only if they ignore doctors' orders on how to take the pills, medical officials said on Monday.
LONDON (Reuters) - U.S. regulators have "serious concerns" about painkilling drugs in the class known as COX-2 inhibitors and are due to issue a new ruling on them within days, the Financial Times reported on its Web site on Sunday.
TOKYO (Reuters) - Five people in Japan may have been infected with the bird flu virus after an outbreak among chickens in February, but there is no risk they will develop symptoms and no chance of more infections, the government said on Saturday.
WASHINGTON (Reuters) - U.S. officials who just weeks ago worried that the nation's flu shot supply would run short said on Friday they are expanding the group of people who should get the vaccine so that doses do not go to waste.
CHICAGO (Reuters) - Doctors writing in a prominent medical journal on Friday recommended that physicians stop prescribing Pfizer Inc.'s Bextra painkiller, just as a large study found the drug maker's sister drug, Celebrex, doubled risk of heart attacks.
NEW YORK (Reuters Health) - Results of a new study provide more evidence that being depressed increases the likelihood of developing diabetes.
NEW YORK (Reuters Health) - Over-the-counter (OTC) benzoyl peroxide cream clears up acne as well as prescription antibiotics -- and at a fraction of the cost, according to new study findings released Friday.
NEW YORK (Reuters Health) - Screening for cancer quite often produces a false-positive result, and this can lead to costly -- and ultimately unnecessary -- follow-up testing, according to a new report.
|
|
